BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, Sclafani RA, Agarwal R. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 2003;22:8271-82. [DOI: 10.1038/sj.onc.1207158] [Cited by in Crossref: 162] [Cited by in F6Publishing: 151] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Olguín-Martínez M, Mendieta-Condado E, Contreras-Zentella M, Escamilla JE, Aranda-Fraustro A, El-Hafidi M, Hernández-Muñoz R. Rate of oxidant stress regulates balance between rat gastric mucosa proliferation and apoptosis. Free Radic Biol Med 2006;41:1325-37. [PMID: 17015179 DOI: 10.1016/j.freeradbiomed.2006.07.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
2 Cheung CW, Taylor PJ, Kirkpatrick CM, Vesey DA, Gobe GC, Winterford C, Nicol DL, Johnson DW. Therapeutic value of orally administered silibinin in renal cell carcinoma: manipulation of insulin-like growth factor binding protein-3 levels. BJU Int 2007;100:438-44. [PMID: 17617146 DOI: 10.1111/j.1464-410X.2007.07012.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
3 Bai Y, Chen J, Hu W, Wang L, Wu Y, Yu S. Silibinin Therapy Improves Cholangiocarcinoma Outcomes by Regulating ERK/Mitochondrial Pathway. Front Pharmacol 2022;13:847905. [DOI: 10.3389/fphar.2022.847905] [Reference Citation Analysis]
4 Amawi H, Hussein NA, Ashby CR Jr, Alnafisah R, Sanglard LM, Manivannan E, Karthikeyan C, Trivedi P, Eisenmann KM, Robey RW, Tiwari AK. Bax/Tubulin/Epithelial-Mesenchymal Pathways Determine the Efficacy of Silybin Analog HM015k in Colorectal Cancer Cell Growth and Metastasis. Front Pharmacol 2018;9:520. [PMID: 29875662 DOI: 10.3389/fphar.2018.00520] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
5 Zhong X, Zhu Y, Lu Q, Zhang J, Ge Z, Zheng S. Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of Akt pathway. Toxicology 2006;227:211-6. [PMID: 16949716 DOI: 10.1016/j.tox.2006.07.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
6 Flaig TW, Su LJ, Harrison G, Agarwal R, Glodé LM. Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells. Int J Cancer 2007;120:2028-33. [PMID: 17230508 DOI: 10.1002/ijc.22465] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
7 Buranabunwong N, Ruangrungsi N, Chansriniyom C, Limpanasithikul W. Ethyl acetate extract from Glycosmis parva leaf induces apoptosis and cell-cycle arrest by decreasing expression of COX-2 and altering BCL-2 family gene expression in human colorectal cancer HT-29 cells. Pharm Biol 2015;53:540-7. [PMID: 25356658 DOI: 10.3109/13880209.2014.931442] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
8 Zhang Y, Li Q, Ge Y, Chen Y, Chen J, Dong Y, Shi W. Silibinin Triggers Apoptosis and Cell-Cycle Arrest of SGC7901 Cells: SILIBININ CELL-CYCLE ARREST SGC7901. Phytother Res 2013;27:397-403. [DOI: 10.1002/ptr.4733] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
9 Schmit TL, Ledesma MC, Ahmad N. Modulating polo-like kinase 1 as a means for cancer chemoprevention. Pharm Res 2010;27:989-98. [PMID: 20107874 DOI: 10.1007/s11095-010-0051-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
10 Kauntz H, Bousserouel S, Gossé F, Raul F. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells. Apoptosis 2012;17:797-809. [PMID: 22555452 DOI: 10.1007/s10495-012-0731-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
11 Volate SR, Davenport DM, Muga SJ, Wargovich MJ. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis. 2005;26:1450-1456. [PMID: 15831530 DOI: 10.1093/carcin/bgi089] [Cited by in Crossref: 158] [Cited by in F6Publishing: 142] [Article Influence: 9.3] [Reference Citation Analysis]
12 Raina K, Kumar S, Dhar D, Agarwal R. Silibinin and colorectal cancer chemoprevention: a comprehensive review on mechanisms and efficacy. J Biomed Res 2016;30:452-65. [PMID: 27476880 DOI: 10.7555/JBR.30.20150111] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
13 Deep G, Singh RP, Agarwal C, Kroll DJ, Agarwal R. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin. Oncogene. 2006;25:1053-1069. [PMID: 16205633 DOI: 10.1038/sj.onc.1209146] [Cited by in Crossref: 106] [Cited by in F6Publishing: 105] [Article Influence: 6.6] [Reference Citation Analysis]
14 Thongphasuk P, Stremmel W, Chamulitrat W. Potent direct or TNF-alpha-promoted anticancer effects of 2,3-dehydrosilybin: comparison study with silybin. Chemotherapy 2008;54:23-30. [PMID: 18063863 DOI: 10.1159/000112314] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
15 Tailor D, Hahm ER, Kale RK, Singh SV, Singh RP. Sodium butyrate induces DRP1-mediated mitochondrial fusion and apoptosis in human colorectal cancer cells. Mitochondrion. 2014;16:55-64. [PMID: 24177748 DOI: 10.1016/j.mito.2013.10.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
16 Mashhadi Akbar Boojar M, Mashhadi Akbar Boojar M, Golmohammad S. Overview of Silibinin anti-tumor effects. Journal of Herbal Medicine 2020;23:100375. [DOI: 10.1016/j.hermed.2020.100375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
17 Singh C, Shyanti RK, Singh V, Kale RK, Mishra JPN, Singh RP. Integrin expression and glycosylation patterns regulate cell-matrix adhesion and alter with breast cancer progression. Biochem Biophys Res Commun. 2018;499:374-380. [PMID: 29577899 DOI: 10.1016/j.bbrc.2018.03.169] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
18 Nawara HM, Afify SM, Hassan G, Zahra MH, Seno A, Seno M. Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy. Biomedicines 2021;9:500. [PMID: 34063205 DOI: 10.3390/biomedicines9050500] [Reference Citation Analysis]
19 Yang SH, Lin JK, Huang CJ, Chen WS, Li SY, Chiu JH. Silibinin inhibits angiogenesis via Flt-1, but not KDR, receptor up-regulation. J Surg Res 2005;128:140-6. [PMID: 15993897 DOI: 10.1016/j.jss.2005.04.042] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
20 McCarty MF, Block KI. Multifocal angiostatic therapy: an update. Integr Cancer Ther 2005;4:301-14. [PMID: 16282507 DOI: 10.1177/1534735405282475] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
21 Chen PN, Hsieh YS, Chiang CL, Chiou HL, Yang SF, Chu SC. Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J Dent Res 2006;85:220-5. [PMID: 16498067 DOI: 10.1177/154405910608500303] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 5.2] [Reference Citation Analysis]
22 Gopalakrishnan A, Xu C-, Nair SS, Chen C, Hebbar V, Kong A-T. Modulation of activator protein-1 (AP-1) and MAPK pathway by flavonoids in human prostate cancer PC3 cells. Arch Pharm Res 2006;29:633-44. [DOI: 10.1007/bf02968247] [Cited by in Crossref: 47] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
23 Raina K, Tyagi A, Kumar D, Agarwal R, Agarwal C. Role of oxidative stress in cytotoxicity of grape seed extract in human bladder cancer cells. Food Chem Toxicol 2013;61:187-95. [PMID: 23831192 DOI: 10.1016/j.fct.2013.06.039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
24 Corchete P. Silybum marianum (L.) Gaertn: the Source of Silymarin. In: Ramawat K, Merillon J, editors. Bioactive Molecules and Medicinal Plants. Berlin: Springer Berlin Heidelberg; 2008. pp. 123-48. [DOI: 10.1007/978-3-540-74603-4_6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
25 Kaur S, Kumar A, Thakur S, Kumar K, Sharma R, Sharma A, Singh P, Sharma U, Kumar S, Landi M, Brestič M, Kaur S. Antioxidant, Antiproliferative and Apoptosis-Inducing Efficacy of Fractions from Cassia fistula L. Leaves. Antioxidants (Basel) 2020;9:E173. [PMID: 32093300 DOI: 10.3390/antiox9020173] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
26 Fehér J, Lengyel G. Silymarin in the treatment of chronic liver diseases: Past and future. Clinical and Experimental Medical Journal 2009;3:403-13. [DOI: 10.1556/cemed.3.2009.28519] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
27 Tiwari P, Kumar A, Balakrishnan S, Kushwaha HS, Mishra KP. Silibinin-induced apoptosis in MCF7 and T47D human breast carcinoma cells involves caspase-8 activation and mitochondrial pathway. Cancer Invest 2011;29:12-20. [PMID: 21166494 DOI: 10.3109/07357907.2010.535053] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
28 Lu W, Lin C, King TD, Chen H, Reynolds RC, Li Y. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells. Cell Signal 2012;24:2291-6. [PMID: 22820499 DOI: 10.1016/j.cellsig.2012.07.009] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 7.2] [Reference Citation Analysis]
29 Arimochi H, Morita K. Desipramine induces apoptotic cell death through nonmitochondrial and mitochondrial pathways in different types of human colon carcinoma cells. Pharmacology 2008;81:164-72. [PMID: 18025841 DOI: 10.1159/000111144] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
30 Odom RY, Dansby MY, Rollins-Hairston AM, Jackson KM, Kirlin WG. Phytochemical induction of cell cycle arrest by glutathione oxidation and reversal by N-acetylcysteine in human colon carcinoma cells. Nutr Cancer 2009;61:332-9. [PMID: 19373606 DOI: 10.1080/01635580802549982] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
31 Tandon M, Salamoun JM, Carder EJ, Farber E, Xu S, Deng F, Tang H, Wipf P, Wang QJ. SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest. PLoS One 2015;10:e0119346. [PMID: 25747583 DOI: 10.1371/journal.pone.0119346] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
32 Křen V, Walterová D. Silybin and silymarin - new effects and applications. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005;149:29-41. [DOI: 10.5507/bp.2005.002] [Cited by in Crossref: 236] [Cited by in F6Publishing: 146] [Article Influence: 13.9] [Reference Citation Analysis]
33 Karim BO, Rhee KJ, Liu G, Zheng D, Huso DL. Chemoprevention utility of silibinin and Cdk4 pathway inhibition in Apc(-/+) mice. BMC Cancer. 2013;13:157. [PMID: 23530816 DOI: 10.1186/1471-2407-13-157] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
34 Jung HJ, Lee DG. Synergistic antibacterial effect between silybin and N,N'-dicyclohexylcarbodiimide in clinical Pseudomonas aeruginosa isolates. J Microbiol 2008;46:462-7. [PMID: 18758739 DOI: 10.1007/s12275-008-0138-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
35 Amado NG, Fonseca BF, Cerqueira DM, Neto VM, Abreu JG. Flavonoids: potential Wnt/beta-catenin signaling modulators in cancer. Life Sci. 2011;89:545-554. [PMID: 21635906 DOI: 10.1016/j.lfs.2011.05.003] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 5.8] [Reference Citation Analysis]
36 Singh RP, Agarwal R. Prostate cancer chemoprevention by silibinin: bench to bedside. Mol Carcinog 2006;45:436-42. [PMID: 16637061 DOI: 10.1002/mc.20223] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 5.9] [Reference Citation Analysis]
37 Singh RP, Agarwal R. Mechanisms and preclinical efficacy of silibinin in preventing skin cancer. Eur J Cancer 2005;41:1969-79. [PMID: 16084079 DOI: 10.1016/j.ejca.2005.03.033] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 5.7] [Reference Citation Analysis]
38 Ding S, Chen G, Zhang W, Xing C, Xu X, Xie H, Lu A, Chen K, Guo H, Ren Z. MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinoma. J Transl Med. 2015;13:237. [PMID: 26198300 DOI: 10.1186/s12967-015-0588-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
39 Gao Y, Theng SS, Mah WC, Lee CG. Silibinin down-regulates FAT10 and modulate TNF-α/IFN-γ-induced chromosomal instability and apoptosis sensitivity. Biol Open 2015;4:961-9. [PMID: 26142316 DOI: 10.1242/bio.011189] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
40 Kim JS, Han NK, Kim SH, Lee HJ. Silibinin attenuates radiation-induced intestinal fibrosis and reverses epithelial-to-mesenchymal transition. Oncotarget 2017;8:69386-97. [PMID: 29050211 DOI: 10.18632/oncotarget.20624] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
41 Sangeetha N, Aranganathan S, Nalini N. Silibinin ameliorates oxidative stress induced aberrant crypt foci and lipid peroxidation in 1, 2 dimethylhydrazine induced rat colon cancer. Invest New Drugs 2010;28:225-33. [DOI: 10.1007/s10637-009-9237-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
42 Sarita Rajender P, Ramasree D, Bhargavi K, Vasavi M, Uma V. Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer—a review. Journal of Receptors and Signal Transduction 2010;30:206-13. [DOI: 10.3109/10799893.2010.488649] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
43 Tang FY, Pai MH, Chiang EP. Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model. J Nutr Biochem. 2012;23:1302-1313. [PMID: 22221675 DOI: 10.1016/j.jnutbio.2011.07.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
44 Morley KL, Ferguson PJ, Koropatnick J. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Letters 2007;251:168-78. [DOI: 10.1016/j.canlet.2006.11.016] [Cited by in Crossref: 146] [Cited by in F6Publishing: 128] [Article Influence: 9.7] [Reference Citation Analysis]
45 Jang CH, Moon N, Oh J, Kim JS. Luteolin Shifts Oxaliplatin-Induced Cell Cycle Arrest at G₀/G₁ to Apoptosis in HCT116 Human Colorectal Carcinoma Cells. Nutrients 2019;11:E770. [PMID: 30987009 DOI: 10.3390/nu11040770] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
46 Arimochi H, Morita K. Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells. Eur J Pharmacol. 2006;541:17-23. [PMID: 16753142 DOI: 10.1016/j.ejphar.2006.04.053] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 3.7] [Reference Citation Analysis]
47 Deep G, Agarwal R. Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer. Cancer Metastasis Rev 2010;29:447-63. [PMID: 20714788 DOI: 10.1007/s10555-010-9237-0] [Cited by in Crossref: 149] [Cited by in F6Publishing: 129] [Article Influence: 12.4] [Reference Citation Analysis]
48 Lin J, Weng M. Flavonoids as Nutraceuticals. In: Grotewold E, editor. The Science of Flavonoids. New York: Springer; 2006. pp. 213-38. [DOI: 10.1007/978-0-387-28822-2_8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
49 Amirsaadat S, Jafari-gharabaghlou D, Alijani S, Mousazadeh H, Dadashpour M, Zarghami N. Metformin and Silibinin co-loaded PLGA-PEG nanoparticles for effective combination therapy against human breast cancer cells. Journal of Drug Delivery Science and Technology 2021;61:102107. [DOI: 10.1016/j.jddst.2020.102107] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
50 Vundru SS, Kale RK, Singh RP. β-Sitosterol induces G1 arrest and causes depolarization of mitochondrial membrane potential in breast carcinoma MDA-MB-231 cells. BMC Complement Altern Med 2013;13:280. [PMID: 24160369 DOI: 10.1186/1472-6882-13-280] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
51 Shete MB, Deshpande AS, Shende P. Silybin-based herbal nanocarriers: an advancement in anticancer therapy. Materials Technology. [DOI: 10.1080/10667857.2022.2081286] [Reference Citation Analysis]
52 Pagnotta E, Calonghi N, Boga C, Masotti L. N-methylformamide and 9-hydroxystearic acid: two anti-proliferative and differentiating agents with different modes of action in colon cancer cells. Anticancer Drugs 2006;17:521-6. [PMID: 16702808 DOI: 10.1097/00001813-200606000-00005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
53 Jahanafrooz Z, Motamed N, Rinner B, Mokhtarzadeh A, Baradaran B. Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator. Life Sci 2018;213:236-47. [PMID: 30308184 DOI: 10.1016/j.lfs.2018.10.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
54 Derry M, Raina K, Agarwal R, Agarwal C. Differential effects of grape seed extract against human colorectal cancer cell lines: the intricate role of death receptors and mitochondria. Cancer Lett 2013;334:69-78. [PMID: 23268334 DOI: 10.1016/j.canlet.2012.12.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
55 Cui W, Gu F, Hu KQ. Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J Gastroenterol 2009; 15(16): 1943-1950 [PMID: 19399925 DOI: 10.3748/wjg.15.1943] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
56 Kim S, Kim K, Yu S, Park S, Choi H, Ji J, Ahn S. Autophagy inhibition enhances silibinin-induced apoptosis by regulating reactive oxygen species production in human prostate cancer PC-3 cells. Biochemical and Biophysical Research Communications 2015;468:151-6. [DOI: 10.1016/j.bbrc.2015.10.143] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
57 Hoh CSL, Boocock DJ, Marczylo TH, Brown VA, Cai H, Steward WP, Berry DP, Gescher AJ. Quantitation of Silibinin, a Putative Cancer Chemopreventive Agent Derived from Milk Thistle ( Silybum marianum ), in Human Plasma by High-Performance Liquid Chromatography and Identification of Possible Metabolites. J Agric Food Chem 2007;55:2532-5. [DOI: 10.1021/jf063156c] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
58 Yang X, Li X, An L, Bai B, Chen J. Silibinin induced the apoptosis of Hep-2 cells via oxidative stress and down-regulating survivin expression. Eur Arch Otorhinolaryngol 2013;270:2289-97. [PMID: 23580032 DOI: 10.1007/s00405-013-2444-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
59 Nawaz Q, Fuentes-chandía M, Tharmalingam V, Ur Rehman MA, Leal-egaña A, Boccaccini AR. Silibinin releasing mesoporous bioactive glass nanoparticles with potential for breast cancer therapy. Ceramics International 2020;46:29111-9. [DOI: 10.1016/j.ceramint.2020.08.083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
60 Tuli HS, Mittal S, Aggarwal D, Parashar G, Parashar NC, Upadhyay SK, Barwal TS, Jain A, Kaur G, Savla R, Sak K, Kumar M, Varol M, Iqubal A, Sharma AK. Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance. Semin Cancer Biol 2021;73:196-218. [PMID: 33130037 DOI: 10.1016/j.semcancer.2020.09.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
61 Varga Z, Seres I, Nagy E, Ujhelyi L, Balla G, Balla J, Antus S. Structure prerequisite for antioxidant activity of silybin in different biochemical systems in vitro. Phytomedicine 2006;13:85-93. [DOI: 10.1016/j.phymed.2004.06.019] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
62 Ge Y, Zhang Y, Chen Y, Li Q, Chen J, Dong Y, Shi W. Silibinin causes apoptosis and cell cycle arrest in some human pancreatic cancer cells. Int J Mol Sci 2011;12:4861-71. [PMID: 21954330 DOI: 10.3390/ijms12084861] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
63 Tung NH, Du GJ, Yuan CS, Shoyama Y, Wang CZ. Isolation and chemopreventive evaluation of novel naphthoquinone compounds from Alkanna tinctoria. Anticancer Drugs 2013;24:1058-68. [PMID: 24025561 DOI: 10.1097/CAD.0000000000000017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
64 Dutto I, Tillhon M, Cazzalini O, Stivala LA, Prosperi E. Biology of the cell cycle inhibitor p21CDKN1A: molecular mechanisms and relevance in chemical toxicology. Arch Toxicol 2015;89:155-78. [DOI: 10.1007/s00204-014-1430-4] [Cited by in Crossref: 107] [Cited by in F6Publishing: 107] [Article Influence: 13.4] [Reference Citation Analysis]
65 Kavitha CV, Agarwal C, Agarwal R, Deep G. Asiatic acid inhibits pro-angiogenic effects of VEGF and human gliomas in endothelial cell culture models. PLoS One 2011;6:e22745. [PMID: 21826202 DOI: 10.1371/journal.pone.0022745] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
66 Raina K, Agarwal C, Wadhwa R, Serkova NJ, Agarwal R. Energy deprivation by silibinin in colorectal cancer cells: a double-edged sword targeting both apoptotic and autophagic machineries. Autophagy. 2013;9:697-713. [PMID: 23445752 DOI: 10.4161/auto.23960] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
67 Mahira S, Kommineni N, Husain GM, Khan W. Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer. Biomed Pharmacother 2019;110:803-17. [PMID: 30554119 DOI: 10.1016/j.biopha.2018.11.145] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
68 Zurlo D, Leone C, Assante G, Salzano S, Renzone G, Scaloni A, Foresta C, Colantuoni V, Lupo A. Cladosporol a stimulates G1-phase arrest of the cell cycle by up-regulation of p21(waf1/cip1) expression in human colon carcinoma HT-29 cells. Mol Carcinog. 2013;52:1-17. [PMID: 22025467 DOI: 10.1002/mc.20872] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
69 Kaur M, Velmurugan B, Tyagi A, Deep G, Katiyar S, Agarwal C, Agarwal R. Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft. Mol Cancer Ther 2009;8:2366-74. [PMID: 19638451 DOI: 10.1158/1535-7163.MCT-09-0304] [Cited by in Crossref: 62] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
70 Weng Y, Kong X, Yu Y, Wang Y, Hong J, Zhao S, Fang J. The role of ERK2 in colorectal carcinogenesis is partly regulated by TRAPPC4: TRAPPC4 PARTLY REGULATE ERK2 IN CRC. Mol Carcinog 2014;53:E72-84. [DOI: 10.1002/mc.22031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
71 Zhu XX, Ding YH, Wu Y, Qian LY, Zou H, He Q. Silibinin: a potential old drug for cancer therapy. Expert Rev Clin Pharmacol. 2016; 18: 1-8 Epub ahead of print. [PMID: 27362364 DOI: 10.1080/17512433.2016.1208563] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
72 Nambiar DK, Rajamani P, Deep G, Jain AK, Agarwal R, Singh RP. Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling. Mol Cancer Ther 2015;14:2722-34. [PMID: 26516160 DOI: 10.1158/1535-7163.MCT-15-0348] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 3.4] [Reference Citation Analysis]
73 Rajamanickam S, Velmurugan B, Kaur M, Singh RP, Agarwal R. Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin. Cancer Res. 2010;70:2368-2378. [PMID: 20215518 DOI: 10.1158/0008-5472.can-09-3249] [Cited by in Crossref: 62] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
74 Hudson EA, Fox LH, Luckett JC, Manson MM. Ex vivo cancer chemoprevention research possibilities. Environmental Toxicology and Pharmacology 2006;21:204-14. [DOI: 10.1016/j.etap.2005.07.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
75 Aborehab NM, Osama N. Effect of Gallic acid in potentiating chemotherapeutic effect of Paclitaxel in HeLa cervical cancer cells. Cancer Cell Int 2019;19:154. [PMID: 31171918 DOI: 10.1186/s12935-019-0868-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
76 Colombo V, Lupi M, Falcetta F, Forestieri D, D'Incalci M, Ubezio P. Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells. Cancer Chemother Pharmacol 2011;67:369-79. [PMID: 20431887 DOI: 10.1007/s00280-010-1335-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
77 Hogan FS, Krishnegowda NK, Mikhailova M, Kahlenberg MS. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer. J Surg Res. 2007;143:58-65. [PMID: 17950073 DOI: 10.1016/j.jss.2007.03.080] [Cited by in Crossref: 106] [Cited by in F6Publishing: 101] [Article Influence: 7.1] [Reference Citation Analysis]
78 Liou W, Chen L, Niu H, Yang T, Cheng J, Lin K. Herbal product silibinin-induced programmed cell death is enhanced by metformin in cervical cancer cells at the dose without influence on nonmalignant cells. J Appl Biomed 2015;13:113-21. [DOI: 10.1016/j.jab.2014.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
79 Yassin NYS, AbouZid SF, El-Kalaawy AM, Ali TM, Almehmadi MM, Ahmed OM. Silybum marianum total extract, silymarin and silibinin abate hepatocarcinogenesis and hepatocellular carcinoma growth via modulation of the HGF/c-Met, Wnt/β-catenin, and PI3K/Akt/mTOR signaling pathways. Biomed Pharmacother 2021;145:112409. [PMID: 34781148 DOI: 10.1016/j.biopha.2021.112409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
80 Roy S, Singh RP, Agarwal C, Siriwardana S, Sclafani R, Agarwal R. Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype. Cell Cycle 2008;7:1828-35. [PMID: 18583941 DOI: 10.4161/cc.7.12.6024] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
81 Tiwari P, Kumar A, Ali M, Mishra KP. Radioprotection of plasmid and cellular DNA and Swiss mice by silibinin. Mutat Res 2010;695:55-60. [PMID: 19945544 DOI: 10.1016/j.mrgentox.2009.11.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
82 Ghasemi R, Ghaffari SH, Momeny M, Pirouzpanah S, Yousefi M, Malehmir M, Alimoghaddam K, Ghavamzadeh A. Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells. Nutr Cancer. 2013;65:590-599. [PMID: 23659451 DOI: 10.1080/01635581.2013.770043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
83 Sameri S, Saidijam M, Bahreini F, Najafi R. Cancer Chemopreventive Activities of Silibinin on Colorectal Cancer through Regulation of E-Cadherin/β-Catenin Pathway. Nutr Cancer 2021;73:1389-99. [PMID: 32748663 DOI: 10.1080/01635581.2020.1800764] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
84 Garg G, Khandelwal A, Blagg BS. Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects. Adv Cancer Res 2016;129:51-88. [PMID: 26916001 DOI: 10.1016/bs.acr.2015.12.001] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 13.0] [Reference Citation Analysis]
85 Kavitha CV, Deep G, Gangar SC, Jain AK, Agarwal C, Agarwal R. Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, and AP-1 activation in RAW264.7 cells. Mol Carcinog 2014;53:169-80. [PMID: 23115104 DOI: 10.1002/mc.21959] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
86 Khammanivong A, Wang C, Sorenson BS, Ross KF, Herzberg MC. S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma. PLoS One 2013;8:e69395. [PMID: 23874958 DOI: 10.1371/journal.pone.0069395] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
87 Singh RP, Deep G, Chittezhath M, Kaur M, Dwyer-Nield LD, Malkinson AM, Agarwal R. Effect of silibinin on the growth and progression of primary lung tumors in mice. J Natl Cancer Inst 2006;98:846-55. [PMID: 16788158 DOI: 10.1093/jnci/djj231] [Cited by in Crossref: 119] [Cited by in F6Publishing: 107] [Article Influence: 7.4] [Reference Citation Analysis]
88 Kaur M, Agarwal R. Silymarin and epithelial cancer chemoprevention: how close we are to bedside? Toxicol Appl Pharmacol 2007;224:350-9. [PMID: 17184801 DOI: 10.1016/j.taap.2006.11.011] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
89 Evren E, Yurtcu E. In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin. Folia Microbiol (Praha) 2015;60:351-6. [PMID: 25937395 DOI: 10.1007/s12223-015-0399-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
90 Woo J, Shin S, Cho E, Ryu D, Garandeau D, Chajra H, Fréchet M, Park D, Jung E. Senotherapeutic-like effect of Silybum marianum flower extract revealed on human skin cells. PLoS One 2021;16:e0260545. [PMID: 34914725 DOI: 10.1371/journal.pone.0260545] [Reference Citation Analysis]
91 Li W, Mu D, Song L, Zhang J, Liang J, Wang C, Liu N, Tian F, Li X, Zhang W, Wang X. Molecular mechanism of silymarin-induced apoptosis in a highly metastatic lung cancer cell line anip973. Cancer Biother Radiopharm 2011;26:317-24. [PMID: 21711112 DOI: 10.1089/cbr.2010.0892] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
92 Gu S, Tian Y, Chlenski A, Salwen HR, Lu Z, Raj JU, Yang Q. Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma. Anticancer Drugs 2012;23:1054-66. [PMID: 22863973 DOI: 10.1097/CAD.0b013e32835739dd] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
93 Rajamanickam S, Agarwal R. Natural products and colon cancer: current status and future prospects. Drug Dev Res 2008;69:460-71. [PMID: 19884979 DOI: 10.1002/ddr.20276] [Cited by in Crossref: 105] [Cited by in F6Publishing: 90] [Article Influence: 7.5] [Reference Citation Analysis]
94 Rajamanickam S, Kaur M, Velmurugan B, Singh RP, Agarwal R. Silibinin suppresses spontaneous tumorigenesis in APC min/+ mouse model by modulating beta-catenin pathway. Pharm Res 2009;26:2558-67. [PMID: 19779968 DOI: 10.1007/s11095-009-9968-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
95 Patel S, Waghela B, Shah K, Vaidya F, Mirza S, Patel S, Pathak C, Rawal R. Silibinin, A Natural Blend In Polytherapy Formulation For Targeting Cd44v6 Expressing Colon Cancer Stem Cells. Sci Rep 2018;8:16985. [PMID: 30451890 DOI: 10.1038/s41598-018-35069-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
96 Malavolta M, Bracci M, Santarelli L, Sayeed MA, Pierpaoli E, Giacconi R, Costarelli L, Piacenza F, Basso A, Cardelli M, Provinciali M. Inducers of Senescence, Toxic Compounds, and Senolytics: The Multiple Faces of Nrf2-Activating Phytochemicals in Cancer Adjuvant Therapy. Mediators Inflamm 2018;2018:4159013. [PMID: 29618945 DOI: 10.1155/2018/4159013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
97 Koosha S, Alshawsh MA, Looi CY, Seyedan A, Mohamed Z. An Association Map on the Effect of Flavonoids on the Signaling Pathways in Colorectal Cancer. Int J Med Sci 2016;13:374-85. [PMID: 27226778 DOI: 10.7150/ijms.14485] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
98 Deep G, Agarwal R. Chemopreventive Efficacy of Silymarin in Skin and Prostate Cancer. Integr Cancer Ther 2007;6:130-45. [DOI: 10.1177/1534735407301441] [Cited by in Crossref: 80] [Cited by in F6Publishing: 65] [Article Influence: 13.3] [Reference Citation Analysis]
99 Bang CI, Paik SY, Sun DI, Joo YH, Kim MS. Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line. Ann Otol Rhinol Laryngol 2008;117:781-5. [PMID: 18998509 DOI: 10.1177/000348940811701014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
100 Kumar S, Raina K, Agarwal C, Agarwal R. Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4/6-mediated survival signals. Oncotarget 2014;5:4972-89. [PMID: 24970802 DOI: 10.18632/oncotarget.2068] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
101 Fehér J, Lengyel G. [Silymarin in the treatment of chronic liver diseases: past and future]. Orv Hetil 2008;149:2413-8. [PMID: 19073452 DOI: 10.1556/OH.2008.28519] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
102 Rigon C, Marchiori MCL, da Silva Jardim F, Pegoraro NS, Chaves PDS, Velho MC, Beck RCR, Ourique AF, Sari MHM, Oliveira SMD, Cruz L. Hydrogel containing silibinin nanocapsules presents effective anti-inflammatory action in a model of irritant contact dermatitis in mice. European Journal of Pharmaceutical Sciences 2019;137:104969. [DOI: 10.1016/j.ejps.2019.104969] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
103 Ting H, Deep G, Agarwal R. Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer. AAPS J 2013;15:707-16. [PMID: 23588585 DOI: 10.1208/s12248-013-9486-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
104 Ali SA, Saifi MA, Godugu C, Talla V. Silibinin alleviates silica-induced pulmonary fibrosis: Potential role in modulating inflammation and epithelial-mesenchymal transition. Phytother Res 2021. [PMID: 34250649 DOI: 10.1002/ptr.7210] [Reference Citation Analysis]
105 Li L, Zeng J, Gao Y, He D. Targeting silibinin in the antiproliferative pathway. Expert Opinion on Investigational Drugs 2010;19:243-55. [DOI: 10.1517/13543780903533631] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
106 Su CH, Chen LJ, Liao JF, Cheng JT. Increase of phosphatase and tensin homolog by silymarin to inhibit human pharynx squamous cancer. J Med Food. 2013;16:778-784. [PMID: 23909904 DOI: 10.1089/jmf.2012.2534] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
107 Yu HC, Chen LJ, Cheng KC, Li YX, Yeh CH, Cheng JT. Silymarin inhibits cervical cancer cell through an increase of phosphatase and tensin homolog. Phytother Res. 2012;26:709-715. [PMID: 22016029 DOI: 10.1002/ptr.3618] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
108 Raina K, Agarwal C, Agarwal R. Effect of silibinin in human colorectal cancer cells: targeting the activation of NF-κB signaling. Mol Carcinog 2013;52:195-206. [PMID: 22086675 DOI: 10.1002/mc.21843] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
109 Kaipa JM, Starkuviene V, Erfle H, Eils R, Gladilin E. Transcriptome profiling reveals Silibinin dose-dependent response network in non-small lung cancer cells. PeerJ 2020;8:e10373. [PMID: 33362957 DOI: 10.7717/peerj.10373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
110 Tyagi A, Sharma Y, Agarwal C, Agarwal R. Silibinin impairs constitutively active TGFalpha-EGFR autocrine loop in advanced human prostate carcinoma cells. Pharm Res 2008;25:2143-50. [PMID: 18253818 DOI: 10.1007/s11095-008-9545-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
111 Delmas D, Xiao J, Vejux A, Aires V. Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity. Molecules 2020;25:E2009. [PMID: 32344919 DOI: 10.3390/molecules25092009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 13.5] [Reference Citation Analysis]
112 Zhang Y, Ge Y, Chen Y, Li Q, Chen J, Dong Y, Shi W. Cellular and molecular mechanisms of silibinin induces cell-cycle arrest and apoptosis on HeLa cells. Cell Biochem Funct 2012;30:243-8. [PMID: 22170400 DOI: 10.1002/cbf.1842] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
113 Mateen S, Tyagi A, Agarwal C, Singh RP, Agarwal R. Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators. Mol Carcinog. 2010;49:247-258. [PMID: 19908243 DOI: 10.1002/mc.20595] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
114 Panieri E, Buha A, Telkoparan-Akillilar P, Cevik D, Kouretas D, Veskoukis A, Skaperda Z, Tsatsakis A, Wallace D, Suzen S, Saso L. Potential Applications of NRF2 Modulators in Cancer Therapy. Antioxidants (Basel) 2020;9:E193. [PMID: 32106613 DOI: 10.3390/antiox9030193] [Cited by in F6Publishing: 41] [Reference Citation Analysis]
115 Zhang M, Liu Y, Gao Y, Li S. Silibinin-induced glioma cell apoptosis by PI3K-mediated but Akt-independent downregulation of FoxM1 expression. Eur J Pharmacol 2015;765:346-54. [PMID: 26342429 DOI: 10.1016/j.ejphar.2015.08.057] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
116 Lin Q, Lai R, Chirieac LR, Li C, Thomazy VA, Grammatikakis I, Rassidakis GZ, Zhang W, Fujio Y, Kunisada K. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. Am J Pathol. 2005;167:969-980. [PMID: 16192633 DOI: 10.1016/s0002-9440(10)61187-x] [Cited by in Crossref: 145] [Cited by in F6Publishing: 86] [Article Influence: 8.5] [Reference Citation Analysis]
117 Gu M, Dhanalakshmi S, Mohan S, Singh RP, Agarwal R. Silibinin inhibits ultraviolet B radiation-induced mitogenic and survival signaling, and associated biological responses in SKH-1 mouse skin. Carcinogenesis 2005;26:1404-13. [PMID: 15831527 DOI: 10.1093/carcin/bgi096] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
118 Cheng YY, Hsieh CH, Tsai TH. Concurrent administration of anticancer chemotherapy drug and herbal medicine on the perspective of pharmacokinetics. J Food Drug Anal 2018;26:S88-95. [PMID: 29703390 DOI: 10.1016/j.jfda.2018.01.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
119 Raina K, Agarwal R. Promise and potential of silibinin in colorectal cancer management: what patterns can be seen? Future Oncol 2013;9:759-61. [PMID: 23718291 DOI: 10.2217/fon.13.51] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
120 Kim SH, Kim KY, Yu SN, Seo YK, Chun SS, Yu HS, Ahn SC. Silibinin induces mitochondrial NOX4-mediated endoplasmic reticulum stress response and its subsequent apoptosis. BMC Cancer 2016;16:452. [PMID: 27405931 DOI: 10.1186/s12885-016-2516-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
121 Noori-daloii MR, Saffari M, Raoofian R, Yekaninejad M, Dinehkabodi OS, Noori-daloii AR. The multidrug resistance pumps are inhibited by silibinin and apoptosis induced in K562 and KCL22 leukemia cell lines. Leukemia Research 2014;38:575-80. [DOI: 10.1016/j.leukres.2013.10.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
122 Feng W, Cai D, Zhang B, Lou G, Zou X. Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in pancreatic cancer cells. Biomed Pharmacother 2015;74:257-64. [PMID: 26349994 DOI: 10.1016/j.biopha.2015.08.017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
123 Li L, Gao Y, Zhang L, Zeng J, He D, Sun Y. Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR–ERK activation in renal cell carcinoma. Cancer Letters 2008;272:61-9. [DOI: 10.1016/j.canlet.2008.06.033] [Cited by in Crossref: 62] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
124 Subramaniam D, Ramalingam S, Houchen CW, Anant S. Cancer stem cells: a novel paradigm for cancer prevention and treatment. Mini Rev Med Chem 2010;10:359-71. [PMID: 20370703 DOI: 10.2174/138955710791330954] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 5.3] [Reference Citation Analysis]
125 Ou T, Wang C, Lee Y, Wu C, Lee H. Gallic acid induces G2/M phase cell cycle arrest via regulating 14-3-3β release from Cdc25C and Chk2 activation in human bladder transitional carcinoma cells. Mol Nutr Food Res 2010;54:1781-90. [DOI: 10.1002/mnfr.201000096] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
126 Amawi H, Hussein NA, Karthikeyan C, Manivannan E, Wisner A, Williams FE, Samuel T, Trivedi P, Ashby CR Jr, Tiwari AK. HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity Studies. Front Pharmacol 2017;8:498. [PMID: 28824426 DOI: 10.3389/fphar.2017.00498] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
127 Dizaji MZ, Malehmir M, Ghavamzadeh A, Alimoghaddam K, Ghaffari SH. Synergistic Effects of Arsenic Trioxide and Silibinin on Apoptosis and Invasion in Human Glioblastoma U87MG Cell Line. Neurochem Res 2012;37:370-80. [DOI: 10.1007/s11064-011-0620-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
128 Tyagi AK, Agarwal C, Singh RP, Shroyer KR, Glode LM, Agarwal R. Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells. Biochem Biophys Res Commun. 2003;312:1178-1184. [PMID: 14651997 DOI: 10.1016/j.bbrc.2003.11.038] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
129 Chen C, Huang T, Wong C, Hong C, Tsai Y, Liang C, Lu F, Chang W. Synergistic anti-cancer effect of baicalein and silymarin on human hepatoma HepG2 Cells. Food and Chemical Toxicology 2009;47:638-44. [DOI: 10.1016/j.fct.2008.12.024] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
130 Derry MM, Raina K, Agarwal C, Agarwal R. Identifying molecular targets of lifestyle modifications in colon cancer prevention. Front Oncol 2013;3:119. [PMID: 23675573 DOI: 10.3389/fonc.2013.00119] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
131 Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
132 Hahm E, Jin DH, Kang JS, Kim YI, Hong SW, Lee SK, Kim HN, Jung DJ, Kim JE, Shin DH, Hwang YI, Kim YS, Hur DY, Yang Y, Cho D, Lee MS, Lee WJ. The molecular mechanisms of vitamin C on cell cycle regulation in B16F10 murine melanoma. J Cell Biochem 2007;102:1002-10. [PMID: 17455238 DOI: 10.1002/jcb.21336] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
133 Kobori M, Yoshida M, Ohnishi-Kameyama M, Shinmoto H. Ergosterol peroxide from an edible mushroom suppresses inflammatory responses in RAW264.7 macrophages and growth of HT29 colon adenocarcinoma cells. Br J Pharmacol 2007;150:209-19. [PMID: 17160010 DOI: 10.1038/sj.bjp.0706972] [Cited by in Crossref: 111] [Cited by in F6Publishing: 92] [Article Influence: 6.9] [Reference Citation Analysis]
134 Singh RP, Agarwal R. A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer. Mutat Res. 2004;555:21-32. [PMID: 15476849 DOI: 10.1016/j.mrfmmm.2004.05.017] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
135 Dagne A, Melkamu T, Schutten MM, Qian X, Upadhyaya P, Luo X, Kassie F. Enhanced inhibition of lung adenocarcinoma by combinatorial treatment with indole-3-carbinol and silibinin in A/J mice. Carcinogenesis 2011;32:561-7. [PMID: 21273642 DOI: 10.1093/carcin/bgr010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
136 Kauntz H, Bousserouel S, Gossé F, Raul F. Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells. Apoptosis. 2011;16:1042-1053. [PMID: 21779837 DOI: 10.1007/s10495-011-0631-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 5.6] [Reference Citation Analysis]
137 Fan L, Ma Y, Liu Y, Zheng D, Huang G. Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells. European Journal of Pharmacology 2014;743:79-88. [DOI: 10.1016/j.ejphar.2014.09.019] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
138 Ezhilarasan D, Evraerts J, Sid B, Calderon PB, Karthikeyan S, Sokal E, Najimi M. Silibinin induces hepatic stellate cell cycle arrest via enhancing p53/p27 and inhibiting Akt downstream signaling protein expression. Hepatobiliary & Pancreatic Diseases International 2017;16:80-7. [DOI: 10.1016/s1499-3872(16)60166-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
139 Velmurugan B, Gangar SC, Kaur M, Tyagi A, Deep G, Agarwal R. Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules. Pharm Res 2010;27:2085-97. [PMID: 20628792 DOI: 10.1007/s11095-010-0207-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
140 Cheung CW, Vesey DA, Nicol DL, Johnson DW. Silibinin inhibits renal cell carcinoma via mechanisms that are independent of insulin-like growth factor-binding protein 3. BJU Int 2007;99:454-60. [DOI: 10.1111/j.1464-410x.2007.06571.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
141 Wang Y, Wang C, Jiang C, Zeng H, He X. Novel mechanism of harmaline on inducing G2/M cell cycle arrest and apoptosis by up-regulating Fas/FasL in SGC-7901 cells. Sci Rep 2015;5:18613. [PMID: 26678950 DOI: 10.1038/srep18613] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
142 Pashaei-Asl F, Pashaei-Asl R, Khodadadi K, Akbarzadeh A, Ebrahimie E, Pashaiasl M. Enhancement of anticancer activity by silibinin and paclitaxel combination on the ovarian cancer. Artif Cells Nanomed Biotechnol 2018;46:1483-7. [PMID: 28884602 DOI: 10.1080/21691401.2017.1374281] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
143 Chen YH, Lin H, Wang Q, Hou JW, Mao ZJ, Li YG. Protective role of silibinin against myocardial ischemia/reperfusion injury-induced cardiac dysfunction. Int J Biol Sci 2020;16:1972-88. [PMID: 32398964 DOI: 10.7150/ijbs.39259] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
144 Lee MH, Huang Z, Kim DJ, Kim SH, Kim MO, Lee SY, Xie H, Park SJ, Kim JY, Kundu JK. Direct targeting of MEK1/2 and RSK2 by silybin induces cell-cycle arrest and inhibits melanoma cell growth. Cancer Prev Res (Phila). 2013;6:455-465. [PMID: 23447564 DOI: 10.1158/1940-6207.capr-12-0425] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
145 Velmurugan B, Singh RP, Tyagi A, Agarwal R. Inhibition of azoxymethane-induced colonic aberrant crypt foci formation by silibinin in male Fisher 344 rats. Cancer Prev Res (Phila) 2008;1:376-84. [PMID: 19138982 DOI: 10.1158/1940-6207.CAPR-08-0059] [Cited by in Crossref: 41] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
146 Momeny M, Khorramizadeh MR, Ghaffari SH, Yousefi M, Yekaninejad MS, Esmaeili R, Jahanshiri Z, Nooridaloii MR. Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation. European Journal of Pharmacology 2008;591:13-20. [DOI: 10.1016/j.ejphar.2008.06.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
147 Singh RP, Dhanalakshmi S, Agarwal C, Agarwal R. Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-κB: implications for angioprevention and antiangiogenic therapy. Oncogene 2005;24:1188-202. [DOI: 10.1038/sj.onc.1208276] [Cited by in Crossref: 94] [Cited by in F6Publishing: 94] [Article Influence: 5.2] [Reference Citation Analysis]
148 Singh RP, Raina K, Deep G, Chan D, Agarwal R. Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling. Clin Cancer Res 2009;15:613-21. [PMID: 19147767 DOI: 10.1158/1078-0432.CCR-08-1846] [Cited by in Crossref: 73] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
149 Chang HR, Chen PN, Yang SF, Sun YS, Wu SW, Hung TW, Lian JD, Chu SC, Hsieh YS. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel. Mol Carcinog 2011;50:811-23. [PMID: 21574189 DOI: 10.1002/mc.20756] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
150 Li W, Zhao X, Lv X, Han W, Wang H. Silibinin Retards Colitis-associated Carcinogenesis by Repression of Cdc25C in Mouse Model. Inflammatory Bowel Diseases 2019;25:1187-95. [DOI: 10.1093/ibd/izz007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
151 Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B, Ribatti D, Chen YC, Honoki K, Fujii H, Georgakilas AG, Nowsheen S, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich B, Yang X, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Halicka D, Mohammed SI, Azmi AS, Bilsland A, Keith WN, Jensen LD. Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol 2015;35 Suppl:S224-43. [PMID: 25600295 DOI: 10.1016/j.semcancer.2015.01.001] [Cited by in Crossref: 245] [Cited by in F6Publishing: 225] [Article Influence: 35.0] [Reference Citation Analysis]
152 Zhu Y, Gu YX, Mo JJ, Shi JY, Qiao SC, Lai HC. N-acetyl cysteine protects human oral keratinocytes from Bis-GMA-induced apoptosis and cell cycle arrest by inhibiting reactive oxygen species-mediated mitochondrial dysfunction and the PI3K/Akt pathway. Toxicol In Vitro 2015;29:2089-101. [PMID: 26343756 DOI: 10.1016/j.tiv.2015.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
153 Sánchez-sampedro A, Kim HK, Choi YH, Verpoorte R, Corchete P. Metabolomic alterations in elicitor treated Silybum marianum suspension cultures monitored by nuclear magnetic resonance spectroscopy. Journal of Biotechnology 2007;130:133-42. [DOI: 10.1016/j.jbiotec.2007.03.007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
154 Nambiar D, Prajapati V, Agarwal R, Singh RP. In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells. Cancer Lett 2013;334:109-17. [PMID: 23022268 DOI: 10.1016/j.canlet.2012.09.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
155 Mohan S, Dhanalakshmi S, Mallikarjuna GU, Singh RP, Agarwal R. Silibinin modulates UVB-induced apoptosis via mitochondrial proteins, caspases activation, and mitogen-activated protein kinase signaling in human epidermoid carcinoma A431 cells. Biochem Biophys Res Commun. 2004;320:183-189. [PMID: 15207719 DOI: 10.1016/j.bbrc.2004.05.153] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
156 Kaur M, Velmurugan B, Tyagi A, Agarwal C, Singh RP, Agarwal R. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling. Neoplasia 2010;12:415-24. [PMID: 20454513 DOI: 10.1593/neo.10188] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 6.3] [Reference Citation Analysis]